Efficacy and Safety of HCP1102 Capsule

NCT02552667 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma With Allergic Rhinitis

Interventions

DRUG: HCP1102+HGP0711Placebo
DRUG: HCP1102Placebo+HGP0711

Sponsor

Hanmi Pharmaceutical Company Limited